Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution

Gyros Protein Technologies AB today announced a partnership with offer Biotage®.

GH-21 by HUYA Bioscience International for Head And Neck Cancer Squamous Cell Carcinoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 28, 2023

Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Half Year Results 15.08.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement.

August 16, 2023

TLM-005 by Therillume for Glioblastoma Multiforme (GBM): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

November 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.